Royce & Associates’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-243,335
Closed -$12.6M 962
2022
Q3
$12.6M Buy
243,335
+62,455
+35% +$3.71M 0.14% 207
2022
Q2
$9.51M Buy
+180,880
New +$12.6M 0.1% 294

Other funds holding THC

Royce & Associates's THC Position: Q4 2022 in Review

Royce & Associates sold out of Tenet Healthcare (THC) in Q4 2022, closing a stake of 243,335 shares — an estimated $12.6M sold.

Royce & Associates first reported a position in THC in Q2 2022 and held it in 2 quarters. The position peaked at $12.6M in Q3 2022. 354 funds tracked by Wall St. Rank hold THC as of Q4 2022.

  • Royce & Associates reported no remaining Tenet Healthcare position as of Q4 2022 after selling out during the quarter.
  • Royce & Associates sold 243,335 Tenet Healthcare shares in Q4 2022, an estimated $12.6M.
  • Royce & Associates first reported a position in Tenet Healthcare in Q2 2022 and held it in 2 quarters.
  • Royce & Associates's Tenet Healthcare position peaked at $12.6M in Q3 2022.
  • 354 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2022.

Based on Royce & Associates's 13F filing for Q4 2022, filed 13 Feb 2023.